Liên Minh Châu Âu - Tiếng Hà Lan - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - chondrogenic geïnduceerde paarden allogene perifere bloed-derived mesenchymal stem cells - andere geneesmiddelen voor aandoeningen van het musculo-skeletale systeem - paarden - vermindering van milde tot matige terugkerende kreupelheid in verband met de niet-septische gewrichtsontsteking bij paarden.

Liên Minh Châu Âu - Tiếng Hà Lan - EMA (European Medicines Agency)

plethora pharma solutions limited - lidocaine, prilocaine - premature ejaculatie - anesthetica - senstend is geïndiceerd voor de behandeling van primaire vroegtijdige zaadlozing bij volwassen mannen.

Liên Minh Châu Âu - Tiếng Hà Lan - EMA (European Medicines Agency)

dechra regulatory b.v. - mirtazapine - psychoanaleptics, antidepressants in combination with psycholeptics - cats - voor het lichaamsgewicht in katten last hebt van een slechte eetlust en gewichtsverlies als gevolg van chronische medische aandoeningen.

Liên Minh Châu Âu - Tiếng Hà Lan - EMA (European Medicines Agency)

heron therapeutics, b.v. - bupivacaine, meloxicam - pijn, postoperatieve - anesthetica - zynrelef is indicated for treatment of somatic postoperative pain from small- to medium-sized surgical wounds in adults (see section 5.

Liên Minh Châu Âu - Tiếng Hà Lan - EMA (European Medicines Agency)

pacira ireland limited - bupivacaine - acute pain - amides, anesthetics, local - exparel liposomal is indicated:in adults as a brachial plexus block or femoral nerve block for treatment of post-operative pain. in adults and children aged 6 years or older as a field block for treatment of somatic post-operative pain from small- to medium-sized surgical wounds.

Liên Minh Châu Âu - Tiếng Hà Lan - EMA (European Medicines Agency)

laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - varkens - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies). to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies. to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies). mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.

Liên Minh Châu Âu - Tiếng Hà Lan - EMA (European Medicines Agency)

almirall, s.a. - tirbanibulin - keratosis, actinic - antibiotica en chemotherapeutica voor dermatologisch gebruik - klisyri is indicated for the field treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis (olsen grade 1) of the face or scalp in adults.

Liên Minh Châu Âu - Tiếng Hà Lan - EMA (European Medicines Agency)

intervacc ab - recombinant streptococcus equi protein cce, recombinant streptococcus equi protein eq85, recombinant streptococcus equi protein idee - immunologicals voor paardachtigen - paarden - for the active immunisation to reduce clinical signs and the number of abscesses in acute stage of infection with s. equi.

Liên Minh Châu Âu - Tiếng Hà Lan - EMA (European Medicines Agency)

vbi vaccines b.v. - hepatitis b-oppervlakte-antigeen - hepatitis b - vaccins - prehevbri is indicated for active immunisation against infection caused by all known subtypes of the hepatitis b virus in adults. it can be expected that hepatitis d will also be prevented by immunisation with prehevbri as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection. the use of prehevbri should be in accordance with official recommendations.

Liên Minh Châu Âu - Tiếng Hà Lan - EMA (European Medicines Agency)

baxter holding b.v. - doxorubicine hydrochloride - sarcoma, kaposi; multiple myeloma; ovarian neoplasms; breast neoplasms - antineoplastische middelen - caelyx gepegyleerd liposomaal is aangegeven:als monotherapie bij patiënten met gemetastaseerde borstkanker, waar sprake is van een verhoogde cardiale risico ' s;voor de behandeling van gevorderde eierstokkanker bij vrouwen die niet in een eerste-lijn op platina gebaseerde chemotherapie regime;in combinatie met bortezomib voor de behandeling van progressieve multiple myeloom bij patiënten die ten minste één eerdere therapie en die al hebben ondergaan, of zijn niet geschikt voor beenmergtransplantatie;voor de behandeling van aids-gerelateerde kaposi sarcoom (ks) bij patiënten met lage cd4-tellingen (.